Usefulness of biomarkers in population studies: From exposure to susceptibility and to prediction of cancer

被引:37
作者
Au, William W. [1 ]
机构
[1] Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA
关键词
biomarkers; population studies; susceptibility; DNA adducts; chromosome aberrations; gene mutations; challenge assay; mutagen sensitivity assay; cancer risk assessment;
D O I
10.1016/j.ijheh.2006.11.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
From a review of decades of intensive biomarker research and prospective validation studies, it becomes clear that only a limited number of blomarkers can be used to provide reliable documentation of excessive exposure to environmental mutagenic agents, expression of detrimental biological effects from the exposure and increased risk for cancer. These studies also demonstrate that expression of each biomarker represents an integrated response to the exposure that is influenced by susceptibility factors, and an integral component of the complex carcinogenic pathway. A current interest is in the use of phenotypic functional assays to improve and complement the assessment of cancer risk. A recommended approach includes assays that indicate DNA repair deficiency, i.e. host-cell-mediated reporter gene and challenge (mutagen-sensitivity) assays. The usefulness and limitations in biomarker investigations will be discussed. The review emphasizes the need for carefully designed investigations that involve adequate sample sizes and a combination of appropriate biomarkers to generate reproducible results that can be translated into more reliable cancer risk assessment. The assessment can be used to drive the implementation of disease prevention and intervention activities. Such an approach is consistent with the current priority in translating basic science knowledge into health applications. (C) 2006 Elsevier GmbH. All rights reserved.
引用
收藏
页码:239 / 246
页数:8
相关论文
共 50 条
  • [31] Biomarkers in environmental carcinogenesis research: Striving for a new momentum
    Kyrtopoulos, SA
    [J]. TOXICOLOGY LETTERS, 2006, 162 (01) : 3 - 15
  • [32] Liou SH, 1999, CANCER RES, V59, P1481
  • [33] López-Abente G, 1999, CANCER EPIDEM BIOMAR, V8, P925
  • [34] Solid-tumor mortality in the vicinity of uranium cycle facilities and nuclear power plants in Spain
    López-Abente, G
    Aragonés, N
    Pollán, M
    [J]. ENVIRONMENTAL HEALTH PERSPECTIVES, 2001, 109 (07) : 721 - 729
  • [35] DNA repair polymorphisms and cancer risk in non-smokers in a cohort study
    Matullo, G
    Dunning, AM
    Guarrera, S
    Baynes, C
    Polidoro, S
    Garte, S
    Autrup, H
    Malaveille, C
    Peluso, M
    Airoldi, L
    Veglia, F
    Gormally, E
    Hoek, G
    Krzyzanowski, M
    Overvad, K
    Raaschou-Nielsen, O
    Clavel-Chapelon, F
    Linseisen, J
    Boeing, H
    Trichopoulou, A
    Palli, D
    Krogh, V
    Tumino, R
    Panico, S
    Bueno-De-Mesquita, HB
    Peeters, PH
    Lund, E
    Pera, G
    Martinez, C
    Dorronsoro, M
    Barricarte, A
    Tormo, MJ
    Quiros, JR
    Day, NE
    Key, TJ
    Saracci, R
    Kaaks, R
    Riboli, E
    Vineis, P
    [J]. CARCINOGENESIS, 2006, 27 (05) : 997 - 1007
  • [37] Chromosomal aberrations and SCEs as biomarkers of cancer risk
    Norppa, H.
    Bonassi, S.
    Hansteen, I-L.
    Hagmar, L.
    Stromberg, U.
    Rossner, P.
    Boffetta, P.
    Lindholm, C.
    Gundy, S.
    Lazutka, J.
    Cebulska-Wasilewska, A.
    Fabianova, E.
    Sram, R. J.
    Knudsen, L. E.
    Barale, R.
    Fucic, A.
    [J]. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2006, 600 (1-2) : 37 - 45
  • [38] Genetic susceptibility, biornarker respones, and cancer
    Norppa, H
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2003, 544 (2-3) : 339 - 348
  • [39] Heterogeneity in DNA damage using the comet assay
    Olive, PL
    Durand, RE
    [J]. CYTOMETRY PART A, 2005, 66A (01) : 1 - 8
  • [40] DNA adducts and lung cancer risk: A prospective study
    Peluso, M
    Munnia, A
    Hoek, G
    Krzyzanowski, M
    Veglia, F
    Airoldi, L
    Autrup, H
    Dunning, A
    Garte, S
    Hainaut, P
    Malaveille, C
    Gormally, E
    Matullo, G
    Overvad, K
    Raaschou-Nielsen, O
    Clavel-Chapelon, F
    Linseisen, J
    Boeing, H
    Trichopoulou, A
    Trichopoulos, D
    Kaladidi, A
    Palli, D
    Krogh, V
    Tumino, R
    Panico, S
    Bueno-De-Mesquita, HB
    Peeters, PH
    Kumle, M
    Gonzalez, CA
    Martinez, C
    Dorronsoro, M
    Barricarte, A
    Navarro, C
    Quiros, JR
    Berglund, G
    Janzon, L
    Jarvholm, B
    Day, NE
    Key, TJ
    Saracci, R
    Kaaks, R
    Riboli, E
    Vineis, P
    [J]. CANCER RESEARCH, 2005, 65 (17) : 8042 - 8048